Search research articles
Contact Us
Filters
Showing results (51-60 of 123) with videos related to
Page
of 13
Sort By:
Life Sciences
|
May 7, 1984
Plasma cortisol and catecholamine responses to intracerebroventricular administration of CRF to rhesus monkeys
T R Insel, J A Aloi, D Goldstein, et al.
Psychopharmacology
|
January 1, 1981
Tyramine infusions and selective monoamine oxidase inhibitor treatment. II. Interrelationships among pressor sensitivity changes, platelet MAO inhibition, and plasma MHPG reduction
D Pickar, R M Cohen, D C Jimerson, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 1, 1997
Cerebrospinal fluid leptin in anorexia nervosa: correlation with nutritional status and potential role in resistance to weight gain
C Mantzoros, J S Flier, M D Lesem, et al.
Biological Psychiatry
|
January 1, 1994
Cerebrospinal fluid TRH immunoreactivity in anorexia nervosa
M D Lesem, W H Kaye, G Bissette, et al.
Communications in Psychopharmacology
|
January 1, 1980
Alterations in noradrenergic function during clorgyline treatment
D Pickar, C R Lake, R M Cohen, et al.
Biological Psychiatry
|
June 5, 1999
Salivary gland enlargement and elevated serum amylase in bulimia nervosa
E D Metzger, J M Levine, C R McArdle, et al.
Archives of General Psychiatry
|
November 1, 1981
Plasma MHPG in rapid cyclers and healthy twins
D C Jimerson, J I Nurnberger, R M Post, et al.
Biological Psychiatry
|
February 1, 1980
Preliminary trial of the noradrenergic agonist clonidine in psychiatric patients
D C Jimerson, R M Post, F J Stoddard, et al.
Psychosomatic Medicine
|
March 1, 1994
Alexithymia ratings in bulimia nervosa: clinical correlates
D C Jimerson, B E Wolfe, D L Franko, et al.
Psychiatry Research
|
July 1, 1990
Altered norepinephrine regulation in bulimia: effects of pharmacological challenge with isoproterenol
D T George, W H Kaye, D S Goldstein, et al.
Page
of 13
Search research articles
Search
Showing results (51-60 of 123) with videos related to
Sort By:
Page
of 13
Life Sciences
|
May 7, 1984
Plasma cortisol and catecholamine responses to intracerebroventricular administration of CRF to rhesus monkeys
T R Insel, J A Aloi, D Goldstein, et al.
Psychopharmacology
|
January 1, 1981
Tyramine infusions and selective monoamine oxidase inhibitor treatment. II. Interrelationships among pressor sensitivity changes, platelet MAO inhibition, and plasma MHPG reduction
D Pickar, R M Cohen, D C Jimerson, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 1, 1997
Cerebrospinal fluid leptin in anorexia nervosa: correlation with nutritional status and potential role in resistance to weight gain
C Mantzoros, J S Flier, M D Lesem, et al.
Biological Psychiatry
|
January 1, 1994
Cerebrospinal fluid TRH immunoreactivity in anorexia nervosa
M D Lesem, W H Kaye, G Bissette, et al.
Communications in Psychopharmacology
|
January 1, 1980
Alterations in noradrenergic function during clorgyline treatment
D Pickar, C R Lake, R M Cohen, et al.
Biological Psychiatry
|
June 5, 1999
Salivary gland enlargement and elevated serum amylase in bulimia nervosa
E D Metzger, J M Levine, C R McArdle, et al.
Archives of General Psychiatry
|
November 1, 1981
Plasma MHPG in rapid cyclers and healthy twins
D C Jimerson, J I Nurnberger, R M Post, et al.
Biological Psychiatry
|
February 1, 1980
Preliminary trial of the noradrenergic agonist clonidine in psychiatric patients
D C Jimerson, R M Post, F J Stoddard, et al.
Psychosomatic Medicine
|
March 1, 1994
Alexithymia ratings in bulimia nervosa: clinical correlates
D C Jimerson, B E Wolfe, D L Franko, et al.
Psychiatry Research
|
July 1, 1990
Altered norepinephrine regulation in bulimia: effects of pharmacological challenge with isoproterenol
D T George, W H Kaye, D S Goldstein, et al.
Page
of 13